Dynavax Technologies Corporation (NASDAQ: DVAX) related to its sale to Sanofi. Under the terms of the proposed transaction, Dynavax shareholders are expected to receive $15.50 per share in cash.
Dynavax Technologies Corporation (NASDAQ: DVAX) related to its sale to Sanofi. Under the terms of the proposed transaction, Dynavax shareholders are expected to receive $15.50 per share in cash.